Creatine hydrochloride is creatine bound to hydrochloric acid, which makes it far more soluble in water than creatine monohydrate. It is marketed on that property: a more soluble form, the pitch goes, is better absorbed, so a dose a fraction of the monohydrate dose does the same job without loading, bloating or stomach upset. It costs more per gram.

The monohydrate it is sold against has the largest evidence base of any sports supplement; see the creatine guide. The question for this page is narrower: is there evidence that the hydrochloride form does anything the monohydrate does not? A 2011 review of novel creatine forms found little to none, and the handful of trials since have not changed that much.

Once in the blood, creatine is creatine; the salt form is gone by then. Any difference between forms would have to come from what happens in the glass and the gut: solubility, dissolution and absorption. The hydrochloride is much more soluble. Whether higher solubility means higher absorption is the part that is argued, because monohydrate's absorption was long assumed to be near complete.

A 2018 rat study measured monohydrate's absolute oral bioavailability at 53% for a low dose and 16% for a high dose, and used a pharmacokinetic model to predict that the hydrochloride would reach 66% at the high dose. That is a simulation built on rat data, not a measurement in people, and it is the strongest mechanistic support the form has.

The review. A 2011 analysis of novel creatine forms concluded that monohydrate raises muscle creatine and phosphocreatine by about 15 to 40%, is not degraded in digestion with nearly 99% taken up by muscle or excreted, and has no medically significant side effects on record, while there is little to no evidence that any newer form is more effective or safer.

Head to head, strength. In the strength trial, 40 men aged 18 to 25 did eight weeks of resistance training with creatine hydrochloride at 0.03 g per kg per day, monohydrate with a loading phase, monohydrate without loading, or placebo. All three creatine arms gained more strength, muscle cross-sectional area and lean mass than placebo, with similar hormone shifts. The hydrochloride showed no benefit over monohydrate.

Head to head, sprinting. In the sprint trial, 40 collegiate soccer players did four weeks of repeated sprint training on monohydrate, ethyl ester, hydrochloride or placebo. All creatine arms beat placebo on jump, sprint, agility and peak power; the hydrochloride and ethyl ester arms gained more than monohydrate on those measures. Ten per arm, four weeks, no dose in the abstract, and ethyl ester, which is widely regarded as inferior to monohydrate, outperformed it too, which argues for noise.

Brain creatine. In 36 perimenopausal and menopausal women, 1,500 mg per day of the hydrochloride for eight weeks raised frontal brain creatine (16.4% against 0.9% on placebo) and improved reaction time. A low-dose result worth noting, but there is no monohydrate arm, so it says nothing about the comparison this page is about.

What is missing is the obvious study: muscle creatine content after equal creatine doses of each form in people. Until that exists, 'better absorbed' is a solubility claim wearing a bioavailability costume.

No trial has reported a safety problem specific to the hydrochloride, and the menopausal trial called all doses well tolerated. The caveats are the ones monohydrate carries, and one of its own.

Its own: the hydrochloride has a fraction of monohydrate's human exposure history, so 'no problems reported' rests on a few hundred people over a few weeks rather than decades of use. The 2011 review noted that the regulatory status of newer forms was less clearly defined than monohydrate's in most markets.

Shared: creatine raises serum creatinine, which can be misread as kidney trouble on a standard blood panel; tell whoever orders your labs. People with kidney disease should not take any form without advice.

A dietary supplement ingredient in the United States, sold without review of its claims. In the European Union creatine monohydrate holds an authorized health claim for physical performance in short, high-intensity exercise; that claim belongs to the monohydrate, and the 2011 review's point stands that the regulatory status of other creatine salts is less clearly settled. No regulator has endorsed any superiority of the hydrochloride.